vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and WATSCO INC (WSO). Click either name above to swap in a different company.
WATSCO INC is the larger business by last-quarter revenue ($1.5B vs $950.5M, roughly 1.6× Astrana Health, Inc.). WATSCO INC runs the higher net margin — 6.1% vs 0.7%, a 5.4% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 0.1%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -15.3%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Watsco, Inc. is a distributor of air conditioning, heating and refrigeration equipment, and related parts and supplies (HVAC/R) in the United States. Watsco was founded more than 60 years ago as a manufacturer of parts, components, and tools used in the HVAC/R industry. In 1989, the company shifted from manufacturing to distribution, by acquiring Gemaire Distributors Inc., a South Florida-based Rheem distributor.
ASTH vs WSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.5B |
| Net Profit | $6.6M | $92.9M |
| Gross Margin | — | 27.9% |
| Operating Margin | 1.9% | 7.2% |
| Net Margin | 0.7% | 6.1% |
| Revenue YoY | 42.9% | 0.1% |
| Net Profit YoY | 184.4% | -1.7% |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.5B | ||
| Q4 25 | $950.5M | $1.6B | ||
| Q3 25 | $956.0M | $2.1B | ||
| Q2 25 | $654.8M | $2.1B | ||
| Q1 25 | $620.4M | $1.5B | ||
| Q4 24 | $665.2M | $1.8B | ||
| Q3 24 | $478.7M | $2.2B | ||
| Q2 24 | $486.3M | $2.1B |
| Q1 26 | — | $92.9M | ||
| Q4 25 | $6.6M | $71.7M | ||
| Q3 25 | $373.0K | $161.6M | ||
| Q2 25 | $9.4M | $183.6M | ||
| Q1 25 | $6.7M | $80.1M | ||
| Q4 24 | $-7.8M | $96.8M | ||
| Q3 24 | $16.1M | $171.0M | ||
| Q2 24 | $19.2M | $181.4M |
| Q1 26 | — | 27.9% | ||
| Q4 25 | — | 27.1% | ||
| Q3 25 | — | 27.5% | ||
| Q2 25 | — | 29.3% | ||
| Q1 25 | — | 28.1% | ||
| Q4 24 | — | 26.7% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.1% |
| Q1 26 | — | 7.2% | ||
| Q4 25 | 1.9% | 6.4% | ||
| Q3 25 | 2.0% | 11.4% | ||
| Q2 25 | 3.1% | 13.2% | ||
| Q1 25 | 3.3% | 7.3% | ||
| Q4 24 | 0.1% | 7.8% | ||
| Q3 24 | 5.9% | 11.6% | ||
| Q2 24 | 6.2% | 12.6% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 0.7% | 4.5% | ||
| Q3 25 | 0.0% | 7.8% | ||
| Q2 25 | 1.4% | 8.9% | ||
| Q1 25 | 1.1% | 5.2% | ||
| Q4 24 | -1.2% | 5.5% | ||
| Q3 24 | 3.4% | 7.9% | ||
| Q2 24 | 3.9% | 8.5% |
| Q1 26 | — | — | ||
| Q4 25 | $0.12 | $1.82 | ||
| Q3 25 | $0.01 | $3.98 | ||
| Q2 25 | $0.19 | $4.52 | ||
| Q1 25 | $0.14 | $1.93 | ||
| Q4 24 | $-0.14 | $2.42 | ||
| Q3 24 | $0.33 | $4.22 | ||
| Q2 24 | $0.40 | $4.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $392.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $3.2B |
| Total Assets | $2.2B | $4.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $392.7M | ||
| Q4 25 | $429.5M | $733.3M | ||
| Q3 25 | $463.4M | $524.3M | ||
| Q2 25 | $342.1M | $293.0M | ||
| Q1 25 | $260.9M | $431.8M | ||
| Q4 24 | $290.8M | $781.9M | ||
| Q3 24 | $350.3M | $550.0M | ||
| Q2 24 | $327.7M | $424.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $361.6M | ||
| Q3 25 | — | $340.8M | ||
| Q2 25 | — | $338.7M | ||
| Q1 25 | — | $346.4M | ||
| Q4 24 | — | $337.2M | ||
| Q3 24 | — | $321.0M | ||
| Q2 24 | — | $307.1M |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $779.3M | $2.8B | ||
| Q3 25 | $775.5M | $2.8B | ||
| Q2 25 | $765.5M | $2.8B | ||
| Q1 25 | $745.4M | $2.7B | ||
| Q4 24 | $712.7M | $2.7B | ||
| Q3 24 | $704.6M | $2.7B | ||
| Q2 24 | $678.9M | $2.6B |
| Q1 26 | — | $4.6B | ||
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.2B | $4.6B | ||
| Q2 25 | $1.4B | $4.7B | ||
| Q1 25 | $1.3B | $4.5B | ||
| Q4 24 | $1.4B | $4.5B | ||
| Q3 24 | $1.3B | $4.5B | ||
| Q2 24 | $1.3B | $4.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $399.8M | ||
| Q3 25 | $10.0M | $354.9M | ||
| Q2 25 | $90.9M | $-7.4M | ||
| Q1 25 | $16.6M | $-177.6M | ||
| Q4 24 | $-10.9M | $378.9M | ||
| Q3 24 | $34.0M | $232.8M | ||
| Q2 24 | $23.2M | $57.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $388.5M | ||
| Q3 25 | $7.4M | $346.1M | ||
| Q2 25 | $89.5M | $-14.3M | ||
| Q1 25 | $13.6M | $-185.2M | ||
| Q4 24 | $-13.5M | $370.9M | ||
| Q3 24 | $31.7M | $223.0M | ||
| Q2 24 | $20.4M | $51.3M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 24.6% | ||
| Q3 25 | 0.8% | 16.7% | ||
| Q2 25 | 13.7% | -0.7% | ||
| Q1 25 | 2.2% | -12.1% | ||
| Q4 24 | -2.0% | 21.1% | ||
| Q3 24 | 6.6% | 10.3% | ||
| Q2 24 | 4.2% | 2.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 0.7% | ||
| Q3 25 | 0.3% | 0.4% | ||
| Q2 25 | 0.2% | 0.3% | ||
| Q1 25 | 0.5% | 0.5% | ||
| Q4 24 | 0.4% | 0.5% | ||
| Q3 24 | 0.5% | 0.5% | ||
| Q2 24 | 0.6% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 5.57× | ||
| Q3 25 | 26.69× | 2.20× | ||
| Q2 25 | 9.65× | -0.04× | ||
| Q1 25 | 2.48× | -2.22× | ||
| Q4 24 | — | 3.91× | ||
| Q3 24 | 2.11× | 1.36× | ||
| Q2 24 | 1.21× | 0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
WSO
Segment breakdown not available.
